Company profile

Incorporated in
Fiscal year end

CERC stock data



9 May 19
18 Jun 19
31 Dec 19


Company financial data Financial data

Quarter (USD) Mar 19 Dec 18 Sep 18 Jun 18
Revenue 5.41M 4.98M 4.07M 4.79M
Net income -7.5M -5.61M -24.6M -6.01M
Diluted EPS -0.15 -0.71 -0.19
Net profit margin -139% -112% -604% -126%
Operating income -7.02M -5.85M -24.23M -5.74M
Net change in cash 5.48M 3.85M 4.6M -323.93K
Cash on hand 16.12M 10.65M 6.8M 2.2M
Cost of revenue 1.95M 2.08M 3.11M 1.42M
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 18.33M 27.81M 1.15M 0
Net income -40.1M 11.87M -16.47M -10.49M
Diluted EPS -1.2 0.42 -1.87 -4.71
Net profit margin -219% 42.68% -1429%
Operating income -39.31M 13.89M -16.08M -11.01M
Net change in cash 8.17M -2.66M -16.03M 9.42M
Cash on hand 10.65M 2.47M 5.13M 21.16M
Cost of revenue 7.48M 635.65K 0 0

Financial data from Cerecor earnings reports

Financial report summary

Management Discussion
  • Net product revenue increased $1.2 million for the three months ended March 31, 2019 as compared to the same period in 2018. The increase was due to favorable product mix and unit growth driven by the sales force expansion as well as due to a full quarter of sales of products that were acquired during the prior year quarter.
  • As part of the acquisition of TRx in November 2017, the Company acquired a sales and marketing agreement with Pharmaceutical Associates, Inc. ("PAI") under which the Company received a monthly marketing fee to promote, market and sell certain products on behalf of PAI. The Company was also entitled to a share of PAI's profits. For the three months ended March 31, 2018, sales force revenue was $0.2 million. The PAI contract was canceled during the second quarter of 2018 and therefore there is no sales force revenue for the three months ended March 31, 2019.
  • Cost of product sales was $1.9 million for the three months ended March 31, 2019, compared to $0.9 million for the three months ended March 31, 2018. The increase of $1.0 million for the three months ended March 31, 2019 compared to the same period in 2018 is driven by the increase in net product revenue as well as Lachlan Pharmaceuticals' minimum purchase and royalty obligations that arose during the third quarter of 2018 as further discussed in Note 13 to the accompanying unaudited financial statements appearing above.
Content analysis ?
H.S. junior Avg
New words: adhere, adult, announced, appointed, baseline, blood, borrow, borrowing, Boyd, caption, carryforward, Chairman, challenge, Chemistry, consecutive, counterparty, crossover, Crutcher, dictated, director, dosage, Dr, economic, environment, EPS, exceeded, expedient, expedite, expeditiously, explained, fact, Fast, Greenleaf, guarantee, headcount, headquarter, healthy, hird, implicit, indirect, key, largely, leadership, letter, main, mild, monitor, newly, nonclinical, ODD, outdated, Patrick, payout, Pedder, Peter, pharmacokinetic, placebo, pressure, proceed, purpose, randomized, rapid, ratio, reach, readily, ready, receipt, redundant, rejected, relationship, request, requested, resold, role, ROU, RSU, safe, SBP, Shionogi, Simon, Simplification, smaller, Steven, stipulated, successfully, systolic, threshold, transient, unamortized, underwritten, unvested, User, waiver
Removed: absorb, Abuse, accrual, accurate, achieved, acid, adaptation, adjunctive, advance, affecting, age, alcohol, Alcoholism, allocate, America, amounted, AMPA, antagonist, apply, Aspire, assessed, assignment, assist, attribution, autonomic, aware, Baltimore, bank, BB, began, beneficiary, billed, billing, block, brain, Bulletin, Calculating, calculation, called, capitalization, capped, card, Carlo, category, channel, Chargeback, charged, chewable, clarify, Clarifying, Code, collaboration, collateral, communication, comparing, comparison, compensate, competition, complex, compliance, composition, comprehensive, COMT, COMTi, concentrated, conduct, conducting, consist, consistent, consolidate, constitute, constituted, consummation, controlling, Conversely, credit, creditworthy, customer, damaged, dated, decision, decline, declining, deductibility, delay, deliver, delivery, demand, demonstrated, depict, deposit, deposited, determination, determining, difficult, disclosing, discontinued, discovered, disorder, dispensed, dispensing, disposed, distribute, diversity, dividend, dosing, DSA, duration, dysfunction, earlier, earn, earned, EBITDA, efficacy, Eisai, elimination, enacted, enactment, encourage, enrollment, enterprise, entirety, epilepsy, equivalent, escrow, escrowed, evaluated, examination, exceed, execution, exist, expect, expended, expensed, expensing, experience, expiration, exploit, exposure, extent, external, face, factor, faint, family, federally, feel, field, finalize, forthcoming, framework, franchise, freight, frequently, FSC, fulfill, functionally, gaining, generic, globally, glutamate, government, governmental, granting, Health, high, higher, highly, identify, impacted, importance, improve, incomplete, incorporate, indirectly, individual, inhibit, input, Institute, institution, intend, intended, intercompany, interpretation, investigative, invoice, invoiced, irrespective, landlord, larger, launch, liquid, loan, localized, location, lot, low, lowest, maintenance, maker, making, manage, manufacture, manufactured, match, matching, Maxim, measure, mechanism, Medicaid, mentioned, migration, modification, modified, modulate, modulation, Monte, month, multiple, multivitamin, NASDAQ, National, neurologic, neurotransmitter, NIAAA, NIDA, NMDA, nominal, nonvested, objective, obligate, observed, obsolete, obtaining, older, open, opening, operational, originally, origination, partial, past, peer, people, performance, Periodically, perpetual, Pharm, pharmacovigilance, platform, point, postural, potent, potentially, practicable, prepaid, preparation, primary, Princeton, processed, processing, profile, progression, promise, promised, prompt, propagation, proprietary, prosecution, prospectively, protein, provisional, qualified, quality, quantitative, rating, reader, realizable, realized, rebate, receiving, receptor, recording, recoverable, reduction, region, regularly, remain, rendered, renew, represented, reside, residual, resolved, restructuring, retrospective, retrospectively, return, reversal, reviewed, RSA, SAB, schedule, scope, sector, seeking, segment, seizure, selected, selective, selectively, settled, settlement, shelf, Shin, shipped, shipping, shorten, show, side, Silicon, similarly, Simplifying, sit, site, size, specific, stability, stand, stated, step, stream, strongly, subordinated, substance, substitute, subtype, subunit, succeeded, successive, sudden, suited, summarized, supplement, synaptic, system, systemic, tablet, target, targeting, TARP, taxable, taxation, TCJA, technical, temporary, territorial, territory, titled, toxicology, transmembrane, transmission, travel, ultimate, unauthorized, uncertain, uncertainty, understand, understanding, unexercised, unpaid, utilization, Valley, Veripred, vi, VIE, view, viewed, viewing, vii, wholesaler, yield, Yung